Healthcare & Pharma

Name: DebtCanary Corporate Debt Maturity Database
Creator: DebtCanary
License: https://creativecommons.org/publicdomain/zero/1.0/

The Healthcare & Pharma sector encompasses 15 tracked companies carrying $265.3B in combined long-term debt. Across the sector, $34.4B (7% of maturities) is due within the next 12 months. The majority of obligations ($318.6B) extend beyond five years, providing longer-term refinancing runway.

Companies in Sector

Total Sector Debt

$265.3B

High Risk

Avg Risk Score

2.8

Company	Risk Score	Total Debt	12mo Due	Interest Coverage	Data
Amgen AMGN	5/10 Medium Risk	$57.3B	$4.6B	N/A	Partial
Bristol Myers Squibb BMY	5/10 Medium Risk	$44.1B	$2.0B	N/A	Partial
AbbVie ABBV	4/10 Medium Risk	$64.5B	$6.0B	5.2x	Partial
Cvs Health CVS	4/10 Medium Risk	N/A	$4.0B	1.8x	Complete
Gilead Sciences GILD	3/10 Low Risk	$22.2B	$2.8B	10.6x	Complete
Merck & MRK	3/10 Low Risk	N/A	$2.6B	N/A	Partial
Pfizer PFE	3/10 Low Risk	N/A	$3.0B	N/A	Partial
Unitedhealth Group UNH	3/10 Low Risk	N/A	$6.1B	4.7x	Partial
Zoetis ZTS	3/10 Low Risk	N/A	$0	N/A	Partial
Cigna Group CI	2/10 Low Risk	N/A	$550M	N/A	Partial
Johnson & Johnson JNJ	2/10 Low Risk	$41.4B	$2.0B	N/A	Partial
Eli Lilly LLY	2/10 Low Risk	$29.5B	$781M	N/A	Partial
Biogen BIIB	1/10 Low Risk	$6.3B	$0	N/A	Partial
Regeneron Pharmaceuticals REGN	1/10 Low Risk	N/A	N/A	49.0x	Partial
Vertex Pharmaceuticals Inc / Ma VRTX	1/10 Low Risk	N/A	N/A	N/A	Limited